TRACEY JONES: Open Payments
NPI 1043361355 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,465 in 63 payments from 16 companies in 2025. Trend: 2023 $1,892 · 2024 $2,082 · 2025 $2,465
Food & beverage: $2,465
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $498 |
| Janssen Pharmaceuticals, Inc | 5 | $338 |
| Otsuka America Pharmaceutical, Inc. | 9 | $322 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $291 |
| ABBVIE INC. | 8 | $228 |
| Alkermes, Inc. | 4 | $186 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $149 |
| Vanda Pharmaceuticals Inc. | 2 | $139 |
| Lundbeck LLC | 4 | $108 |
| Supernus Pharmaceuticals, Inc. | 3 | $53 |
Products named: COBENFY, REXULTI, INVEGA SUSTENNA, CAPLYTA, VRAYLAR, LYBALVI, TRINTELLIX, FANAPT.
Industry payments across PA — which companies pay providers there.
